Smartphone app could help wet AMD patients space out eye injections
NCT ID NCT07340372
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a home monitoring app can help people with wet age-related macular degeneration (eAMD) safely extend the time between Aflibercept injections. About 80 adults already receiving this treatment will use the app and have regular eye exams over one to two years. The goal is to see if vision stays stable with longer treatment intervals and to measure patient satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Aflibercept 8 mg injection
What this could lead to
If successful, this could show that home monitoring allows patients with wet AMD to safely extend time between eye injections, reducing clinic visits while maintaining vision.
What could go wrong
This is an observational study with only 80 participants, so results may not apply to everyone. The home monitoring app's accuracy and patient adherence are unproven in this setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXUDATIVE AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Espaço Médico de Coimbra, Lda.
Coimbra, Portugal
Contact
-
Instituto Português de Microcirurgia Ocular, Lda.
Lisbon, Portugal
Contact
-
Unidade Local de Saúde Loures-Odivelas
Loures, Portugal
Contact
-
Unidade Local de Saúde de Coimbra, E.P.E.
Coimbra, Portugal
Contact
-
Unidade Local de Saúde de Leiria, E.P.E.
Leiria, Portugal
Contact
-
Unidade Local de Saúde de Lisboa Ocidental - Hospital de Egas Moniz
Lisbon, Portugal
Contact
-
Unidade Local de Saúde de Santo António, E.P.E.
Porto, Portugal
Contact
-
Unidade Local de Saúde de São João, E.P.E.
Porto, Portugal
Contact